Antileishmanial Drugs Modulate IL-12 Expression and Inflammasome Activation in Primary Human Cells

The Journal of Immunology : Official Journal of the American Association of Immunologists
Sonia AndréJérôme Estaquier

Abstract

Leishmaniases are neglected tropical diseases. The treatment of leishmaniasis relies exclusively on chemotherapy including amphotericin B (AmB), miltefosine (hexadecylphosphocholine), and pentamidine. Besides the fact that these molecules are harmful for patients, little is known about the impact of such antileishmanial drugs on primary human cells in relation to immune function. The present study demonstrates that all antileishmanial drugs inhibit CD4 and CD8 T cell proliferation at the doses that are not related to increased cell death. Our results highlight that antileishmanial drugs have an impact on monocytes by altering the expression of IL-12 induced by LPS, whereas only AmB induced IL-10 secretion; both cytokines are essential in regulating Th1 cell-mediated immunity. Interestingly, IL-12 and anti-IL-10 Abs improved T cell proliferation inhibited by AmB. Furthermore, our results show that in contrast to hexadecylphosphocholine and pentamidine, AmB induced gene expression of the inflammasome pathway. Thus, AmB induced IL-1β and IL-18 secretions, which are reduced by specific inhibitors of caspase activation (Q-VD) and NLRP3 activation (MCC950). Our results reveal previously underestimated effects of antileishmanial drugs...Continue Reading

References

Jun 1, 1977·Annals of Tropical Medicine and Parasitology·B Hentzer, T Kobayasi
Apr 3, 1992·Science·D P CerrettiL A Cannizzaro
Oct 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·K A HogquistD D Chaplin
Mar 1, 1991·Toxicology and Applied Pharmacology·G J RosenthalM I Luster
Jan 1, 1985·International Journal of Immunopharmacology·A FerranteY H Thong
May 1, 1988·The Journal of Infectious Diseases·H DonnellyD Armstrong
Jun 1, 1986·Molecular and Biochemical Parasitology·A K SahaA Bhaduri
Apr 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S D GoodwinT H Grasela
Feb 1, 1996·Archives of Biochemistry and Biophysics·S N Moreno
Jul 1, 1996·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·J Van WauweH Walter
Aug 28, 1998·Science·N A Thornberry, Y Lazebnik
Dec 16, 1998·Lancet·S SundarH W Murray
Feb 2, 2000·International Immunology·K TominagaK Nakanishi
Apr 23, 2002·The Journal of Biological Chemistry·Srinivasa M SrinivasulaEmad S Alnemri
Sep 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jae Kwang YooYoung Chul Sung
Jun 20, 2003·Apoptosis : an International Journal on Programmed Cell Death·T M CasertaT L Brown
Feb 26, 2004·Antimicrobial Agents and Chemotherapy·Caroline ParisJaqueline Bréard
Jun 11, 2004·Nature·Sanjeev MariathasanVishva M Dixit
Aug 30, 2005·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Asrat HailuPiet A Kager
Feb 7, 2007·Antimicrobial Agents and Chemotherapy·Juan Román Luque-Ortega, Luis Rivas
Jun 4, 2008·Antimicrobial Agents and Chemotherapy·Thomas P C DorloPeter J de Vries

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

CD4/CD8 Signaling

Cluster of differentiation 4 and 8 (CD8 and CD8) are glycoproteins founds on the surface of immune cells. Here is the latest research on their role in cell signaling pathways.